Jade Biosciences (JBIO) Return on Capital Employed Growth (1y) (2022 - 2026)
Jade Biosciences (JBIO) Return on Capital Employed Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,861.65 Bn | 66,861.36 Bn | - | 1,648.00 |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.72 Bn | - | - |
| 3 | Akari Therapeutics | 1,071.19 Bn | 1,071.19 Bn | - | 31,429.00 |
| 4 | BeOne Medicines | 469.11 Bn | 464.32 Bn | 1.35 Bn | 1,805.00 |
| 5 | Vertex Pharmaceuticals | 123.03 Bn | 115.78 Bn | 2.59 Bn | 2,503.00 |
| 6 | Regeneron Pharmaceuticals | 70.13 Bn | 61.37 Bn | 3.31 Bn | -105.00 |
| 7 | Belite Bio | 63.44 Bn | 63.44 Bn | - | - |
| 8 | Argenx Se | 55.97 Bn | 50.78 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.53 Bn | 34.52 Bn | 959.66 Mn | 2,400.00 |
| 10 | Jade Biosciences | 1.17 Bn | 861.00 Mn | - | 9,556.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9,556.00 |
| Dec 31, 2025 | 10,204.00 |
| Sep 30, 2025 | 3,735.00 |
| Jun 30, 2025 | 2,296.00 |
| Mar 31, 2025 | -5,135.00 |
| Dec 31, 2024 | -7,591.00 |
| Sep 30, 2024 | -4,085.00 |
| Jun 30, 2024 | -4,853.00 |
| Mar 31, 2024 | -3,678.00 |
| Dec 31, 2023 | -3,005.00 |
| Sep 30, 2023 | -2,458.00 |
| Jun 30, 2023 | -2,969.00 |
| Mar 31, 2023 | -3,143.00 |
| Dec 31, 2022 | -2,683.00 |
| Sep 30, 2022 | -1,629.00 |